-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse DüsseldorfEURSymbol 41X-
ARDELYX INCBörse Börse DüsseldorfEURSymbol 41X
-
ARDELYX INCBörse Börse StuttgartEURSymbol 41X
-
ARDELYX INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 41X
-
ARDELYX INCBörse Quotrix System der Börse DüsseldorfEURSymbol 41X
-
ArdelyxBörse NasdaqISIN US0396971071 WKN: A116X0USDSymbol ARDX
-
ISIN US0396971071 WKN: A116X0USDSymbol ARDX
-
Symbol 41X
-
Symbol 41X
-
Symbol 41X
Währung
EUR
Börse
Börse Düsseldorf Zeitzone: Europe/Berlin
Firmenname
Ardelyx, Inc
Marktkapitalisierung
623.954.816 (+- 0%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
620.909.632 oder 627.000.000
Mitarbeiter
111 (+- 20%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88 oder 133 Mitarbeiter
EBITDA -98.746.000
PEGRatio -0.08
Buchwert 1.455
5 ETFs die in Ardelyx investieren
Dir gefallen die Informationen zu Ardelyx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Ardelyx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Ardelyx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Ardelyx?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
34 News & Informationen zur Ardelyx Aktie
Imara Reports Second Quarter 2021 Financial Results and Business Highlights
Accelerated enrollment in Phase 2b trials in sickle cell disease and beta-thalassemia; interim analyses expected in fourth quarter of 2021 Positive IMR-687 data in sickle cell disease… | August 6, 2021
Ardelyx implements restructuring plan after FDA snub of kidney disease drug (NASDAQ:ARDX)
Ardelyx (ARDX) has implemented a restructuring plan after the FDA turned down the approval of the company’s kidney disease therapy tenapanor in July.The plan expected to be complete in…
ARDX INVESTOR ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline – ARDX
NEW YORK, Aug. 2, 2021 /PRNewswire/ —
WHY: Rosen Law Firm, a global… | August 3, 2021
ARDELYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Ardelyx, Inc. in the United States District Court… | July 31, 2021
ARDX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers of Ardelyx Inc. securities between August 6, 2020 and July 19, 2021, inclusive have until September 28, 2021 to seek appointment as… | July 31, 2021
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Ardelyx Inc. (NASDAQ: ARDX)
Scott+Scott Attorneys at Law LLP , an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit against Ardelyx Inc. and certain Ardelyx officers… | July 30, 2021
INVESTOR ALERT: Scott Scott Attorneys At Law LLP Files Securities Class Action Against Ardelyx Inc. (NASDAQ: ARDX)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. – ARDX
/PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX). Such investors are…
Is Dorian LPG Ltd (LPG) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m. ET Thursday, 42 stocks made new 52-week lows.
Interesting Highlights: DiDi Global (NYSE:DIDI) was the biggest company in terms …
Ademi LLP Investigates Claims Of Securities Fraud Against Ardelyx, Inc.
MILWAUKEE, July 21, 2021 /PRNewswire/ — Ademi LLP is investigating possible securities fraud claims against Ardelyx (Nasdaq: ARDX). The investigation results
SUZUKI PRESIDENT: TOYOTA APPROACHED US, INVITED TO JOIN COMMERCIAL JAPAN PARTNERSHIP PROJECT
SUZUKI PRESIDENT: TOYOTA APPROACHED US, INVITED TO JOIN COMMERCIAL JAPAN PARTNERSHIP PROJECT …
Scott+Scott Attorneys at Law LLP : Announces Investigation into Ardelyx Inc. (ARDX)
Scott+Scott Attorneys at Law LLP , an international shareholder and consumer rights litigation firm, is investigating whether Ardelyx Inc. and certain of its officers and directors violated federal… | July 20, 2021
BRITISH MINISTERS CUT OFF FUNDING TO CHIP FACTORY AFTER SALE TO CHINA – TELEGRAPH
BRITISH MINISTERS CUT OFF FUNDING TO CHIP FACTORY AFTER SALE TO CHINA – TELEGRAPH …
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.62% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.62%
BIDEN TO NAME JONATHAN KANTER AS DOJ ANTITRUST CHIEF – SOURCE FAMILIAR TELLS REUTERS
BIDEN TO NAME JONATHAN KANTER AS DOJ ANTITRUST CHIEF – SOURCE FAMILIAR TELLS REUTERS …
BIDEN TO NAME JONATHAN KANTER AS DOJ ANTITRUST CHIEF – BLOOMBERG REPORTER TWEET
BIDEN TO NAME JONATHAN KANTER AS DOJ ANTITRUST CHIEF – BLOOMBERG REPORTER TWEET …
Mid-Day Market Update: HCA Healthcare Surges On Upbeat Results; Ardelyx Shares Slide
Midway through trading Tuesday, the Dow traded up 1.54% to 34,486.30 while the NASDAQ rose 1.04% to 14,424.02. The S&P also rose, gaining 1.35…
(ARDX) Alert: Johnson Fistel, Investigates Ardelyx Following FDA Notification. Did You Lose Money on Your Ardelyx Investment?
SAN DIEGO, July 20, 2021 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal secu…
Why Ardelyx Stock Is Getting Crushed Today
The FDA doesn't appear to be impressed by the biotech's experimental kidney disease drug.
Futures Rebound From Rout As “Buy The Dip Outweighs Fear” Even As Yield Slide Continues
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Ardelyx downgraded on Wall Street after setback for kidney disease drug (NASDAQ:ARDX)
Ardelyx (ARDX) has lost ~73.0% in the early trading after the company announced that the FDA had identified deficiencies in its marketing application for tenapanor for the control of…
Imara Announces Appointment Of Laura A. Williams, M.D., MPH To Board Of Directors
BOSTON, June 30, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing
Millendo Therapeutics : Tempest Closes Merger with Millendo and Completes PIPE Financing (Form 8-K)
Tempest Closes Merger with Millendo and Completes PIPE Financing
South San Francisco, CA, June 28, 2021 -Tempest Therapeutics, Inc. , a clinical-stage oncology… | June 28, 2021
Pharma, Research, And Medical Leaders Say Kidney Patients Are Key To Care Innovation
/PRNewswire/ — The American Association of Kidney Patients (AAKP) recently hosted its 4th Annual Public Policy Summit entitled Patient Voice & Patient Choice:…
Tempest Closes Merger with Millendo and Completes PIPE Financing
SOUTH SAN FRANCISCO, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage oncology company…
Ardelyx : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FREMONT, Calif. and WALTHAM, Mass., April 16, 2021 /PRNewswire/ — Ardelyx, Inc. , a biopharmaceutical company focused on developing innovative first-in-class medicines to improve… | April 16, 2021
Ardelyx to Receive $5M Milestone Payment as Japan Partner Initiates Phase 3
Implied Volatility Surging for Ardelyx (ARDX) Stock Options
Investors need to pay close attention to Ardelyx (ARDX) stock based on the movements in the options market lately.
The 5 Best Biotech Stocks Under $10
Discoer the best biotech stocks under $10 that can make all the difference in your portfolio. Many investors are keeping an eye on the industry.
Why Ardelyx Stock Soared Today
The company's Japanese partner initiated pivotal late-stage studies of Ardelyx's lead candidate.
Ardelyx : Corporate Presentation January 2021
Passionately committed to improving the lives of patients by discovering, developing and commercializing first- in-class targeted therapies that advance patient care
… | January 12, 2021
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Aileron Therapeutics (NASDAQ:ALRN) stock moved upwards by 33.25% to $1.8 during Friday’s after-market session. This security traded at a volume …